Yellow Fever Drug pipeline report- 2020 is an annual R&D review of Yellow Fever pipeline candidates. The report presents the current status of all major Yellow Fever therapeutic compounds. Detailed insights into Yellow Fever pipeline development, current status, companies, drug profiles and Yellow Fever preclinical and clinical trials are included.
2020 Yellow Fever Pipeline Market Insights Yellow Fever disease overview, 2020 pipeline review, insights into leading companies, dominant mechanism of action, majority of administration route of Yellow Fever therapies, pipeline by phase and others are included.
Yellow Fever pipeline Drug profiles- Active and inactive drug profiles covering information including drug name/synonym, sponsor/collaborators/Developer/originator, drug mechanism, route of administration, orphan drug status, NME, phase, development status, and others are included.
Yellow Fever Therapeutic Drug candidates Both active and inactive Yellow Fever pipeline drug candidates are included in the report
Yellow Fever Clinical Trials and preclinical Studies Yellow Fever In-vitro and In-vivo studies, discovery stage and pre-clinical stage trial details, Clinical trial titles, duration, location, phase, sponsors, and other details are provided.
Yellow Fever pipeline market developments Yellow Fever Pipeline market news and deals including mergers, acquisitions, approvals, collaborations, trial initiations, results, investments, licensing opportunities and others are provided.
Yellow Fever pipeline companies in active development
The report analyzes Yellow Fever pipeline of the below companies- BioCryst Pharmaceuticals Inc, Emergex Vaccines Ltd, Ennaid Therapeutics LLC, Fab’entech SA, GE Healthcare Life Sciences, Heat Biologics Inc, iBio Inc, KinoPharma Inc, Najit Technologies, Tychan Pte Ltd
Report Coverage - What to look out for in 2020 Drugs moving from early stage to mid-to-late stages and drugs to look after in 2020 are included
- Pipeline Snapshot Pipeline candidate count - Drug by phase, mechanism of action, route of administration, designation and others
- Companies 10 Companies investing in Yellow Fever pipeline from discovery stage to pre-registration phase are included
- Drug profiles Over 10 details of each Yellow Fever pipeline candidate are included
- Company Profiles Business overview and contact details of all companies operating in the industry are provided
- Market Developments News, Developments and other recent industry developments are included
Our reports have been used by over 10K customers, including:
The Asia Pacific organoids market is expected to reach US$ 513.74 million in 2027 from US$ 97.02 million in 2019. The market is estimated to grow at a CAGR of 23.1% from 2020 to 2027. Rising adoption of biobanking and tumor modelling and alternatives for animal testing models acting as kingpins are expected to augment the growth of the...
The comprehensive 2,400 page research study on COVID-19 therapeutic and vaccine pipeline candidates, completed, ongoing and planned clinical trials across phases, countries, companies and institutes/hospitals. The global COVID-19 market size outlook remains robust driven by huge potential for administration to 2 billion populations,...
Nordic Regulatory Affairs Market Size, Share & Trends Analysis Report By Service, By Service Provider, By Company Size, By Category, By Product Stage, By Indication, By End-use, By Country, And Segment Forecasts, 2021 - 2028 Nordic Regulatory Affairs Market Growth & Trends The Nordic regulatory...
The global custom antibody market is projected to reach USD 652 million by 2026 from USD 393 million in 2021, at a CAGR of 10.6% during the forecast period.The increasing demand for protein therapeutics is expected to drive the custom antibody market in the coming years. On the other hand, the need for significant capital investments and long...
175 pages •
By The Business Research Company
• Apr 2021
Major players in the polymerase chain reaction (PCR) and real-time polymerase chain reaction (PCR) testing market are Abbott Laboratories, Agilent Technologies Inc., Biomerieux Sa, Bio-Rad Laboratories, F. Hoffmann-La Roche Ltd (Roche Diagnostics), Qiagen N.V., Genmark Diagnostics, Thermo Fisher Scientific Inc., General Electric Company (Ge...
Human Cytomegalovirus Glycoprotein H (gH) - Drugs in Development, 2021 Summary Human Cytomegalovirus Glycoprotein H (gH) - Drugs in Development, 2021 provides in depth analysis on Human Cytomegalovirus Glycoprotein H (gH) targeted pipeline therapeutics. The report provides comprehensive information...
Botulism (Infectious Disease) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Botulism - Drugs in Development, 2021, provides an overview of the Botulism (Infectious Disease) pipeline landscape. Botulism is a rare but serious illness. The...
Cause-Specific Mortality Rate
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.